Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Granulocyte-Colony Stimulating Factor Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Granulocyte-Colony Stimulating Factor Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Capsules
      • 1.3.3 Tablets
      • 1.3.4 Others
    • 1.4 Market Segment by Application
      • 1.4.1 Global Granulocyte-Colony Stimulating Factor Market Share by Application (2019-2025)
      • 1.4.2 Oncological Diseases
      • 1.4.3 Blood Disorders
      • 1.4.4 Growth Hormone Deficiencies
      • 1.4.5 Chronic and Autoimmune Disorders
      • 1.4.6 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Granulocyte-Colony Stimulating Factor Market Size
      • 2.1.1 Global Granulocyte-Colony Stimulating Factor Revenue 2014-2025
      • 2.1.2 Global Granulocyte-Colony Stimulating Factor Sales 2014-2025
    • 2.2 Granulocyte-Colony Stimulating Factor Growth Rate by Regions
      • 2.2.1 Global Granulocyte-Colony Stimulating Factor Sales by Regions 2014-2019
      • 2.2.2 Global Granulocyte-Colony Stimulating Factor Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Granulocyte-Colony Stimulating Factor Sales by Manufacturers
      • 3.1.1 Granulocyte-Colony Stimulating Factor Sales by Manufacturers 2014-2019
      • 3.1.2 Granulocyte-Colony Stimulating Factor Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Granulocyte-Colony Stimulating Factor Revenue by Manufacturers (2014-2019)
      • 3.2.2 Granulocyte-Colony Stimulating Factor Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Granulocyte-Colony Stimulating Factor Market Concentration Ratio (CR5 and HHI)
    • 3.3 Granulocyte-Colony Stimulating Factor Price by Manufacturers
    • 3.4 Key Manufacturers Granulocyte-Colony Stimulating Factor Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Granulocyte-Colony Stimulating Factor Market
    • 3.6 Key Manufacturers Granulocyte-Colony Stimulating Factor Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Capsules Sales and Revenue (2014-2019)
      • 4.1.2 Tablets Sales and Revenue (2014-2019)
      • 4.1.3 Others Sales and Revenue (2014-2019)
    • 4.2 Global Granulocyte-Colony Stimulating Factor Sales Market Share by Type
    • 4.3 Global Granulocyte-Colony Stimulating Factor Revenue Market Share by Type
    • 4.4 Granulocyte-Colony Stimulating Factor Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Granulocyte-Colony Stimulating Factor Sales by Application

    6 United States

    • 6.1 United States Granulocyte-Colony Stimulating Factor Breakdown Data by Company
    • 6.2 United States Granulocyte-Colony Stimulating Factor Breakdown Data by Type
    • 6.3 United States Granulocyte-Colony Stimulating Factor Breakdown Data by Application

    7 European Union

    • 7.1 European Union Granulocyte-Colony Stimulating Factor Breakdown Data by Company
    • 7.2 European Union Granulocyte-Colony Stimulating Factor Breakdown Data by Type
    • 7.3 European Union Granulocyte-Colony Stimulating Factor Breakdown Data by Application

    8 China

    • 8.1 China Granulocyte-Colony Stimulating Factor Breakdown Data by Company
    • 8.2 China Granulocyte-Colony Stimulating Factor Breakdown Data by Type
    • 8.3 China Granulocyte-Colony Stimulating Factor Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Granulocyte-Colony Stimulating Factor Breakdown Data by Company
    • 9.2 Rest of World Granulocyte-Colony Stimulating Factor Breakdown Data by Type
    • 9.3 Rest of World Granulocyte-Colony Stimulating Factor Breakdown Data by Application
    • 9.4 Rest of World Granulocyte-Colony Stimulating Factor Breakdown Data by Countries
      • 9.4.1 Rest of World Granulocyte-Colony Stimulating Factor Sales by Countries
      • 9.4.2 Rest of World Granulocyte-Colony Stimulating Factor Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 BioCad
      • 10.1.1 BioCad Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Granulocyte-Colony Stimulating Factor
      • 10.1.4 Granulocyte-Colony Stimulating Factor Product Introduction
      • 10.1.5 BioCad Recent Development
    • 10.2 Dong-A Socio Group
      • 10.2.1 Dong-A Socio Group Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Granulocyte-Colony Stimulating Factor
      • 10.2.4 Granulocyte-Colony Stimulating Factor Product Introduction
      • 10.2.5 Dong-A Socio Group Recent Development
    • 10.3 Pfizer
      • 10.3.1 Pfizer Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Granulocyte-Colony Stimulating Factor
      • 10.3.4 Granulocyte-Colony Stimulating Factor Product Introduction
      • 10.3.5 Pfizer Recent Development
    • 10.4 Intas Pharmaceuticals
      • 10.4.1 Intas Pharmaceuticals Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Granulocyte-Colony Stimulating Factor
      • 10.4.4 Granulocyte-Colony Stimulating Factor Product Introduction
      • 10.4.5 Intas Pharmaceuticals Recent Development
    • 10.5 Novartis AG
      • 10.5.1 Novartis AG Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Granulocyte-Colony Stimulating Factor
      • 10.5.4 Granulocyte-Colony Stimulating Factor Product Introduction
      • 10.5.5 Novartis AG Recent Development
    • 10.6 Stada Arzneimittel
      • 10.6.1 Stada Arzneimittel Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Granulocyte-Colony Stimulating Factor
      • 10.6.4 Granulocyte-Colony Stimulating Factor Product Introduction
      • 10.6.5 Stada Arzneimittel Recent Development
    • 10.7 Teva Pharmaceutical Industries
      • 10.7.1 Teva Pharmaceutical Industries Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Granulocyte-Colony Stimulating Factor
      • 10.7.4 Granulocyte-Colony Stimulating Factor Product Introduction
      • 10.7.5 Teva Pharmaceutical Industries Recent Development
    • 10.8 Amgen
      • 10.8.1 Amgen Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Granulocyte-Colony Stimulating Factor
      • 10.8.4 Granulocyte-Colony Stimulating Factor Product Introduction
      • 10.8.5 Amgen Recent Development
    • 10.9 Dr. Reddy's Laboratories
      • 10.9.1 Dr. Reddy's Laboratories Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Granulocyte-Colony Stimulating Factor
      • 10.9.4 Granulocyte-Colony Stimulating Factor Product Introduction
      • 10.9.5 Dr. Reddy's Laboratories Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Granulocyte-Colony Stimulating Factor Sales Channels
      • 11.2.2 Granulocyte-Colony Stimulating Factor Distributors
    • 11.3 Granulocyte-Colony Stimulating Factor Customers

    12 Market Forecast

    • 12.1 Global Granulocyte-Colony Stimulating Factor Sales and Revenue Forecast 2019-2025
    • 12.2 Global Granulocyte-Colony Stimulating Factor Sales Forecast by Type
    • 12.3 Global Granulocyte-Colony Stimulating Factor Sales Forecast by Application
    • 12.4 Granulocyte-Colony Stimulating Factor Forecast by Regions
      • 12.4.1 Global Granulocyte-Colony Stimulating Factor Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Granulocyte-Colony Stimulating Factor Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Granulocyte-colony stimulating factor (G-CSF or GCSF), also known as colony-stimulating factor 3 (CSF 3), is a glycoprotein that stimulates the bone marrow to produce granulocytes and stem cellsand release them into the bloodstream.
      Functionally, it is a cytokine and hormone, a type of colony-stimulating factor, and is produced by a number of different tissues. 
      The pharmaceutical analogs of naturally occurring G-CSF are called filgrastim and lenograstim.
      G-CSF also stimulates the survival, proliferation, differentiation, and function of neutrophil precursors and mature neutrophils.
      In 2019, the market size of Granulocyte-Colony Stimulating Factor is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Granulocyte-Colony Stimulating Factor.

      This report studies the global market size of Granulocyte-Colony Stimulating Factor, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Granulocyte-Colony Stimulating Factor sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      BioCad
      Dong-A Socio Group
      Pfizer
      Intas Pharmaceuticals
      Novartis AG
      Stada Arzneimittel
      Teva Pharmaceutical Industries
      Amgen
      Dr. Reddy's Laboratories

      Market Segment by Product Type
      Capsules
      Tablets
      Others

      Market Segment by Application
      Oncological Diseases
      Blood Disorders
      Growth Hormone Deficiencies
      Chronic and Autoimmune Disorders
      Others

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Granulocyte-Colony Stimulating Factor status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Granulocyte-Colony Stimulating Factor manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Granulocyte-Colony Stimulating Factor are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now